Demonstrating comparability in AAV analytical development with mass photometry

In this webinar, Santoshkumar Khatwani (Sangamo Therapeutics) presents his work on establishing an analytical workflow for gene therapy products. He is joined by James Wilkinson (Refeyn), who provides an overview of mass photometry and introduces new SamuxMP product line developments, including automation upgrades for improved workflow efficiency and upcoming GMP-compliant software designed for manufacturing and QC environments. 

Empty capsids in AAV-based gene therapy samples can complicate vector purification and reduce product safety. Watch this webinar to learn:  

• How mass photometry provides fast, serotype-independent AAV analytics  

• Why its strengths make it ideal for efficient, in-process sample characterization 

• Insights from an expert working at Sangamo Therapeutics on how to establish an analytical workflow in AAV development and production 

• How mass photometry enhances GMP-regulated environments and process optimization